Yale Researcher Awarded $40 Million to Lead New VA Study to Evaluate Esketamine for Treatment Resistant Depression
Somaia Mohamed, MD, PhD, associate professor of psychiatry, is lead co-investigator of a Department of Veterans Affairs (VA) study that has been awarded $40 million to evaluate the effectiveness of a novel antidepressant medicine, esketamine, for veterans and others with treatment resistant depression (TRD).
Fucito, DeMartini Awarded Grant by NIAAA
Lisa Fucito, PhD, associate professor of psychiatry, and Kelly DeMartini, PhD, research scientist in psychiatry, have been awarded a $3.21 million grant from the National Institute on Alcohol Abuse and Alcoholism for the study, “Deep Phenotyping of Heavy Drinking in Young Adults with Behavioral Scales, Neuropsychological Tasks, and Smartphone Sensing Technology.”
Study: Purpose in Life and Social Connection Protect Against Suicidal Thoughts and Behaviors During COVID-19 Pandemic
Research has shown that U.S. veterans are at high risk for suicidal thoughts and behaviors and death by suicide. In fact, prior to the pandemic in 2019, veterans accounted for 12 percent of all suicide deaths despite accounting for approximately 6 percent of the total population. A new study led by National Center for PTSD and Yale researchers analyzed data from a nationally representative sample of U.S. veterans to understand how the COVID-19 pandemic may have led to changes in suicidal thoughts and behaviors. The results were published online April 5 in JAMA Psychiatry.
Caldwell, Flores Honored by AAAP, NIDA
Ebony Caldwell, MD MPH, an addiction psychiatry fellow at Yale School of Medicine, has been named a recipient of the American Academy of Addiction Psychiatry (AAAP)/National Institute on Drug Abuse (NIDA) Mentor Facilitated Training Award in Substance Use Disorders Science Dissemination Solicitation. Also honored is Jose Flores, MD, PhD, an Addiction Psychiatry Fellowship program graduate from Yale School of Medicine and the Yale Psychiatry Residency Program.
Neural Valuation of Rewards and Punishments in Posttraumatic Stress Disorder: A Computational Approach
A new Yale study sought to unveil the neural mechanism which may govern deficits in decision making under uncertainty in posttraumatic stress disorder (PTSD). Investigators from the Yale PTSD Stress Lab, directed by Ilan Harpaz-Rotem, PhD, professor of psychiatry and of psychology, and the Yale Decision Neuroscience Lab, directed by Ifat Levy, PhD, associate professor and vice chair of diversity, equity and inclusion in comparative medicine, collaborated on the study, published in Translational Psychiatry.
Study: Daily Consumption of a High-Fat, High-Sugar Snack Alters Reward Circuits in Brain
Snacks high in sugar and fat are great for an occasional treat, but when enjoyed daily for several weeks they can rewire the brain and trigger a shift in eating preferences away from low-fat food, according to a new study in Cell Metabolism.
Study Probes Connection Between Excessive Screen Media Activity and Mental Health Problems in Youth
Smartphones, tablets, gaming systems, and other screen devices have become a major temptation for people of all ages, but a new study is focusing on the possible connection between excessive screen media activity and mental health problems in youth.
Yale Research on Psychedelics Gives Hope to Headache Disorder Community
Medical Director of the Headache Center of Excellence at the West Haven VA Medical Center and Assistant Professor of Neurology Emmanuelle Schindler, MD, PhD is the only researcher in the United States studying psychedelics in headache disorders. Her pioneering research on the therapeutic effects of psilocybin on disorders such as cluster headache and partnership with a patient support group is giving hope to a misunderstood and misdiagnosed patient population.
Tetricus Labs Accepted to One Mind Accelerator Program
Tetricus Labs, a New Haven-based precision psychiatry company that is developing a digital platform to evaluate and monitor patients in mental health treatment, has been accepted to the One Mind Accelerator, a national program which backs early-stage startups. Philip Corlett, PhD, associate professor of psychiatry, is scientific co-founder of Tetricus.